Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06800690 · ClinicalTrials.gov registry record

Impact of Menstrual Phase on Oral Glucose Sensitivity

A clinical trial, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
22
Enrollment target

NCT06800690 is a clinical trial that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 22 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06800690 has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
22 participants
Enrollment target

Study Summary

In this study we are determining whether the hormones associated with the phases of the menstrual cycle (menstruation \& ovulation) influence taste sensitivity to glucose. We hypothesized that women would be more sensitive to oral glucose as assessed by absolute detection threshold during ovulation than when assessed during menstruation. These phases of the cycle are associated with peak plasma estradiol levels and nadir estradiol levels. There is evidence that estrogen can increase the sensitivity of the metabolic signaling pathway of the pancreatic beta-islet cells to stimulate insulin release more readily when glucose is present by increasing sensitivity of the K-ATP channel to ATP. Since the same metabolic signaling pathway is reported to be present in taste tissue, we tested whether peak estrogen levels would enhance taste detection of glucose but not sweeteners that cannot generate ATP, such as sucralose or methyl-D-glucopyranoside (MDG).

Interventions

  • DIAGNOSTIC_TEST Urinary Estrogen Level

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2021-11-03
Est. Completion 2024-12-10

What the Registry Record Tells You About NCT06800690

The ClinicalTrials.gov registry entry for NCT06800690 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Urinary Estrogen Level is the first listed.

NCT06800690 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06800690 about?

NCT06800690 is a clinical study titled "Impact of Menstrual Phase on Oral Glucose Sensitivity". In this study we are determining whether the hormones associated with the phases of the menstrual cycle (menstruation \& ovulation) influence taste sensitivity to glucose. We hypothesized that women would be more sensitive to oral glucose as assessed by absolute detection threshold during ovulation ...

What is the current status of trial NCT06800690?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2021-11-03. Estimated completion is 2024-12-10.

What interventions are being tested in trial NCT06800690?

The interventions under investigation include: Urinary Estrogen Level (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06800690?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.